Last reviewed · How we verify

NCT06331819: VasOSA

Clinical Association Between Obstructive Sleep Apnea, Facial Pigmentation, and Vasovagal Symptoms.

Recruiting now Last updated 19 September 2024
What this trial tests

trial testing In-lab polysomnography in Obstructive Sleep Apnea in 200 participants. Currently enrolling.

Timeline
10 March 2024
Primary endpoint
1 January 2026
1 March 2026

Quick facts

Lead sponsorJordan Collaborating Cardiology Group
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment200
Start date10 March 2024
Primary completion1 January 2026
Estimated completion1 March 2026
Sites1 location across Jordan

Drugs / interventions tested

Conditions studied

Sponsor

Jordan Collaborating Cardiology Group — full company profile →

Who can join

18 and older, any sex, with Obstructive Sleep Apnea or Vasovagal Syncope. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this prospective cohort study is to study patients referred for sleep study by in-lab polysomnography in the Jordan University Hospital and the Jordan Hospital or with an at-home sleep study kit. The main aims are: * To prospectively obtain demographic and clinical information of patients referred for a sleep study. * To determine the diagnostic value of facial discoloration as potential marker for obstructive sleep apnea to increase detection rate for the condition. * To establish a correlation between obstructive sleep apnea and vasovagal symptoms with resulting increased smoking tendency and study the effect of treatment on the disorders. * To determine the association between timing of appearance of obstructive sleep apnea symptoms and initiation of smoking.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Obstructive Sleep Apnea

Currently open trials in the same condition.

Other Jordan Collaborating Cardiology Group trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06331819.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing